189 related articles for article (PubMed ID: 21221572)
21. Purification, immobilization, and biochemical characterization of l-arginine deiminase from thermophilic Aspergillus fumigatus KJ434941: anticancer activity in vitro.
El-Sayed AS; Hassan MN; Nada HM
Biotechnol Prog; 2015; 31(2):396-405. PubMed ID: 25582958
[TBL] [Abstract][Full Text] [Related]
22. A Competitive Flow Cytometry Screening System for Directed Evolution of Therapeutic Enzyme.
Cheng F; Kardashliev T; Pitzler C; Shehzad A; Lue H; Bernhagen J; Zhu L; Schwaneberg U
ACS Synth Biol; 2015 Jul; 4(7):768-75. PubMed ID: 25658761
[TBL] [Abstract][Full Text] [Related]
23. Arginine Deiminase Enzyme Evolving as a Potential Antitumor Agent.
Somani RR; Chaskar PK
Mini Rev Med Chem; 2018; 18(4):363-368. PubMed ID: 27538511
[TBL] [Abstract][Full Text] [Related]
24. Arginine Deiminase: Current Understanding and Applications.
Zarei M; Rahbar MR; Morowvat MH; Nezafat N; Negahdaripour M; Berenjian A; Ghasemi Y
Recent Pat Biotechnol; 2019; 13(2):124-136. PubMed ID: 30569861
[TBL] [Abstract][Full Text] [Related]
25. Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism.
Das K; Butler GH; Kwiatkowski V; Clark AD; Yadav P; Arnold E
Structure; 2004 Apr; 12(4):657-67. PubMed ID: 15062088
[TBL] [Abstract][Full Text] [Related]
26. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production.
Dillon BJ; Holtsberg FW; Ensor CM; Bomalaski JS; Clark MA
Med Sci Monit; 2002 Jul; 8(7):BR248-53. PubMed ID: 12118186
[TBL] [Abstract][Full Text] [Related]
27. Thermostability and Specific-Activity Enhancement of an Arginine Deiminase from Enterococcus faecalis SK23.001 via Semirational Design for l-Citrulline Production.
Cai X; Jiang H; Zhang T; Jiang B; Mu W; Miao M
J Agric Food Chem; 2018 Aug; 66(33):8841-8850. PubMed ID: 30047723
[TBL] [Abstract][Full Text] [Related]
28. Molecular characterization of the arginine deiminase system in Listeria monocytogenes: regulation and role in acid tolerance.
Ryan S; Begley M; Gahan CG; Hill C
Environ Microbiol; 2009 Feb; 11(2):432-45. PubMed ID: 19196274
[TBL] [Abstract][Full Text] [Related]
29. Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancers.
Shen LJ; Shen WC
Curr Opin Mol Ther; 2006 Jun; 8(3):240-8. PubMed ID: 16774044
[TBL] [Abstract][Full Text] [Related]
30. Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells.
Manca A; Sini MC; Izzo F; Ascierto PA; Tatangelo F; Botti G; Gentilcore G; Capone M; Mozzillo N; Rozzo C; Cossu A; Tanda F; Palmieri G
Oncol Rep; 2011 Jun; 25(6):1495-502. PubMed ID: 21424129
[TBL] [Abstract][Full Text] [Related]
31. The role of arginine and the modified arginine deiminase enzyme ADI-PEG 20 in cancer therapy with special emphasis on Phase I/II clinical trials.
Synakiewicz A; Stachowicz-Stencel T; Adamkiewicz-Drozynska E
Expert Opin Investig Drugs; 2014 Nov; 23(11):1517-29. PubMed ID: 24965808
[TBL] [Abstract][Full Text] [Related]
32. The roles of active-site residues in the catalytic mechanism of trans-3-chloroacrylic acid dehalogenase: a kinetic, NMR, and mutational analysis.
Azurmendi HF; Wang SC; Massiah MA; Poelarends GJ; Whitman CP; Mildvan AS
Biochemistry; 2004 Apr; 43(14):4082-91. PubMed ID: 15065850
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of anti-tumor activity in melanoma using arginine deiminase fused with 30Kc19α protein.
Lee H; Park G; Kim S; Son B; Joo J; Park HH; Park TH
Appl Microbiol Biotechnol; 2022 Nov; 106(22):7531-7545. PubMed ID: 36227339
[TBL] [Abstract][Full Text] [Related]
34. Expression and Characterization of Serotype 2 Streptococcus suis Arginine Deiminase.
Maneerat K; Yongkiettrakul S; Jiemsup S; Tongtawe P; Gottschalk M; Srimanote P
J Mol Microbiol Biotechnol; 2017; 27(3):133-146. PubMed ID: 28456803
[TBL] [Abstract][Full Text] [Related]
35. Arginine-Depleting Enzymes - An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies.
Riess C; Shokraie F; Classen CF; Kreikemeyer B; Fiedler T; Junghanss C; Maletzki C
Cell Physiol Biochem; 2018; 51(2):854-870. PubMed ID: 30466103
[TBL] [Abstract][Full Text] [Related]
36. Microbial arginine deiminase: A multifaceted green catalyst in biomedical sciences.
Kawatra A; Dhankhar R; Gulati P
Int J Biol Macromol; 2022 Jan; 196():151-162. PubMed ID: 34920062
[TBL] [Abstract][Full Text] [Related]
37. Engineering pH-tolerant mutants of a cyanide dihydratase.
Wang L; Watermeyer JM; Mulelu AE; Sewell BT; Benedik MJ
Appl Microbiol Biotechnol; 2012 Apr; 94(1):131-40. PubMed ID: 21993481
[TBL] [Abstract][Full Text] [Related]
38. Anti-tumor activity of arginine deiminase from Mycoplasma argini and its growth-inhibitory mechanism.
Takaku H; Matsumoto M; Misawa S; Miyazaki K
Jpn J Cancer Res; 1995 Sep; 86(9):840-6. PubMed ID: 7591961
[TBL] [Abstract][Full Text] [Related]
39. Regression of hepatocellular cancer in a patient treated with arginine deiminase.
Curley SA; Bomalaski JS; Ensor CM; Holtsberg FW; Clark MA
Hepatogastroenterology; 2003; 50(53):1214-6. PubMed ID: 14571701
[TBL] [Abstract][Full Text] [Related]
40. Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells.
Yeh TH; Chen YR; Chen SY; Shen WC; Ann DK; Zaro JL; Shen LJ
Mol Pharm; 2016 Jan; 13(1):262-71. PubMed ID: 26642391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
